Abstract
Clinical OMICsVol. 1, No. 15 Genomic Medicine: Balancing Cost and ValueAlex PhilippidisAlex PhilippidisALEX PHILIPPIDIS specializes in biopharma business news and industry issues. Alex joined GEN in 2011 after four years at GenomeWeb, where he covered research institutes and biotech economic development topics. Previously, Alex worked more than 20 years for various newspapers covering business, science, and general news topics. He has been interviewed and quoted by news outlets that include The New York Times and the BBC. (E-mail Address: aphilippidis@liebertpub.com)Search for more papers by this authorPublished Online:25 Nov 2015https://doi.org/10.1089/clinomi.01.15.05AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 1Issue 15Dec 2014 InformationCopyright © GEN PublishingTo cite this article:Alex Philippidis.Genomic Medicine: Balancing Cost and Value.Clinical OMICs.Dec 2014.11-13.http://doi.org/10.1089/clinomi.01.15.05Published in Volume: 1 Issue 15: November 25, 2015PDF download
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
